ArticleFrontiers in medicine2020

A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquine's Prophylactic Effect Against Infection With SARS-CoV-2.

Serban C MuscaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.